Möchten Sie immer auf dem neuesten Stand bleiben?

Oslo, Norway, 27 April 2023 Please find attached the Annual Report for 2022 for Vistin Pharma ASA. There are no material changes in the financial statements compared to the preliminary full year...

Oslo, Norway, 27th of April 2023 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the first quarter of 2023. Revenue in the first quarter ended at MNOK 101...

Oslo, Norway, 20 April 2023 Vistin Pharma ASA will release its first quarter 2023 results on Thursday 27th of April 2023. Vistin Pharma will host a conference call for all shareholders and...

Oslo, Norway, 17th of February 2023 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the fourth quarter 2022 Det company enjoyed a very strong finishing...

Oslo, Norway, 10 February 2023 Vistin Pharma ASA will release its fourth quarter and preliminary 2022 results on Friday 17th of February 2023. Vistin Pharma will host a conference call for all...

Oslo, Norway, 9 December 2022 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) announces that it has entered into a long-term industrial energy agreement with Statkraft, the leading Norwegian energy...

Oslo, Norway, 26th of October 2022 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the third quarter 2022 Strong revenue growth in the quarter compared...

Oslo, Norway, 18 October 2022 Vistin Pharma ASA will release its third quarter and YTD 2022 results on Wednesday 26th of October 2022. Vistin Pharma will host a conference call for all shareholders...

Oslo, Norway, 19th of August 2022 Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN) today announces the financial results for the second quarter 2022 Revenue in second quarter ended at MNOK 69...

Oslo, Norway, 11 August 2022 Vistin Pharma ASA will release its second quarter and YTD 2022 results on Friday 19th of August 2022. Vistin Pharma will host a conference call for all shareholders...